Skip to main content

Parliamentary debates and questions

S5W-22709: Colin Smyth (South Scotland)

Scottish Labour

Date lodged: 17 April 2019

To ask the Scottish Government what protocols are in place to ensure that the correct procedures are followed when treating people with mucopolysaccharidosis (MPS) who are at risk of allergic reactions, including those who have recorded an antibody build up during enzyme replacement therapy.

Answered by: Jeane Freeman 9 May 2019

There are established guidelines for identification and reduction of allergic reactions throughout Medical services to minimise risk. Protocols include seeking a history of allergy before medical interventions at risk of producing an allergy.